Proclara Biosciences
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
Other Names/Subsidiaries
- NeuroPhage Pharmaceuticals, Inc.
- Proclara Biosciences Australia Pty Ltd
Latest on Proclara Biosciences
Attralus, Inc. has raised a $116m series B financing that it says will bring the first of its pan-amyloid removal (PAR) drug candidates into the clinic and advance development of a diagnostic for det
Big changes were announced at Oculis : the Icelandic clinical-stage biotech named Riad Sherif chief executive officer, succeeding Páll Ragnar Jóhannesson who becomes chief financial officer and
Company Changes AGUIAR-LUCANDER , Renee To: Pharmalink AB , CEO (May) From: Omega Fund Management, Partner & COO Phone: +48 8 411 3005 BRUHN , Suzanne, PhD To: Proclara Biosciences , Pres.
Advantagene Closes $14.2m Series A Round Immuno-oncology firm Advantagene Inc. raised $14.2m through the sale of its Series A convertible preferred shares to undisclosed investors. National Securi